Concert Pharmaceuticals Inc
F:73C
Cash Flow Statement
Cash Flow Statement
Concert Pharmaceuticals Inc
| Dec-2022 | Mar-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(11)
|
(15)
|
(18)
|
(21)
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(3)
|
(3)
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
1
|
1
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
3
|
4
|
|
| Change in Working Capital |
0
|
(0)
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
1
|
|
| Cash from Operating Activities |
(0)
N/A
|
(0)
-15%
|
0
N/A
|
0
-4%
|
0
+28%
|
(0)
N/A
|
(8)
-33 347%
|
(14)
-65%
|
(17)
-21%
|
(18)
-9%
|
|
| Investing Cash Flow | |||||||||||
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
9
|
0
|
0
|
0
|
|
| Other |
1
|
0
|
0
|
0
|
0
|
0
|
8
|
0
|
8
|
8
|
|
| Cash from Financing Activities |
1
N/A
|
0
-61%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
17
N/A
|
0
N/A
|
17
N/A
|
17
0%
|
|
| Change in Cash | |||||||||||
| Net Change in Cash |
0
N/A
|
0
-76%
|
0
-92%
|
0
-4%
|
0
+28%
|
(0)
N/A
|
9
N/A
|
4
-61%
|
0
-88%
|
(1)
N/A
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
(0)
N/A
|
(0)
-15%
|
0
N/A
|
0
-4%
|
0
+28%
|
(0)
N/A
|
(8)
-33 347%
|
(14)
-65%
|
(17)
-21%
|
(18)
-9%
|
|